hyperactive children. J Pediatr 78(6): 985–90.
Cook EH Jr., Stein MA et al. (1995). Association of attention-deficit disorder and the dopamine transporter gene. Am J Hum Genet 56(4): 993–8.
Cragg SJ, Hille CJ et al. (2002). Functional domains in dorsal striatum of the nonhuman primate are defined by the dynamic behavior of dopamine. J Neurosci 22(13): 5705–12.
Dougherty DD, Bonab AA et al. (1999). Dopamine transporter density in patients with attention deficit hyperactivity disorder. Lancet 354(9196): 2132–3.
Endres D, Perloy E, Maier S, Feige B, Nickel K, Goll P, Bubl E, Lange t, Glauche V, Graf E, Ebert D, Sobanski E, Philipsen A, Tebartz van Elst L (2015). Normal neurochemistry in the prefontal and cerebellar brain of adults with attention-deficit hyperactivity disorder. Front Behav Neurosci 9: 242.
Endres D, Tebartz van Elst L, Maier SJ, Feige B, Goll P, Meyer SA, Matthies S, Domschke K, Lange T, Sobanski E, Philipsen A, Nickel K, Perlov E (2019). Neurochemical sex differences in adult ADHD patients: an MRS study. Biol Sex Differ 10 (1): 50.
Ernst M, Zametkin AJ et al. (1998). DOPA decarboxylase activity in attention deficit hyperactivity disorder adults. A [fluorine-18]fluorodopa positron emission tomographic study. J Neurosci 18(15): 5901–7.
Ernst M, Zametkin AJ et al. (1999). High midbrain [18F]DOPA accumulation in children with attention deficit hyperactivity disorder. Am J Psychiatry 156(8): 1209–15.
Faraone SV, Perlis RH et al. (2005). Molecular genetics of attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11): 1313–23.
Frank MJ, Claus ED (2006). Anatomy of a decision: striato-orbitofrontal interactions in reinforcement learning, decision making, and reversal. Psychol Rev 113(2): 300–26.
Frank MJ, Woroch BS et al. (2005). Error-related negativity predicts reinforcement learning and conflict biases. Neuron 47(4): 495–501.
Gainetdinov RR, Jones SR et al. (1999a). Functional hyperdopaminergia in dopamine transporter knock-out mice. Biol Psychiatry 46(3): 303–11.
Gainetdinov RR, Wetsel WC et al. (1999b). Role of serotonin in the paradoxical calming effect of psychostimulants on hyperactivity. Science 283(5400): 397–401.
Grace AA (2001). Psychostimulant actions on dopamine and limbic system function: relevance to the pathophysiology and treatment of ADHD. In: Solanto MV, Arnsten AF (Hrsg.). Stimulant Drugs and ADHD: Basic and Clinical Neuroscience. New York: Oxford University Press. S. 134–155.
Hammerness P, Biederman J, Petty C, Henin A, Moore CM (2012). Brain biochemical effects of methylphenidate treatment using proton magnetic spectroscopy in youth with attention-deficit hyperactivity disorder: a controlled pilot study. CNS Neurosci Ther 18: 34–40.
Hesse S, Ballaschkle O et al. (2006). The striatal dopamine transporter availability is reduced in adults with attention-deficit/hyperactivity disorder. J Nucl Med 47: 142P.
Ilgin N, Senol S et al. (2001). Is increased D2 receptor availability associated with response to stimulant medication in ADHD. Dev Med Child Neurol 43(11): 755–60.
Irwin M, Belendiuk K et al. (1981). Tryptophan metabolism in children with attentional deficit disorder. Am J Psychiatry 138(8): 1082–5.
Jacobs BL, Fornal CA (1995). Serotonin and behavior: a general hypothesis. In: Bloom FE, Kupfer DJ (Eds). Psychopharmacology: The Fourth Generation of Progress. New York: Lippincott Williams & Wilkins. S. 461–469.
Jucaite A, Fernell E et al. (2005). Reduced midbrain dopamine transporter binding in male adolescents with attention-deficit/hyperactivity disorder: association between striatal dopamine markers and motor hyperactivity. Biol Psychiatry 57(3): 229–38.
Kirley A, Lowe N et al. (2003). Association of the 480 bp DAT1 allele with methylphenidate response in a sample of Irish children with ADHD. Am J Med Genet B Neuropsychiatr Genet 121B(1): 50–4.
Krause J (2008). SPECT and PET of the dopamine transporter in attention-deficit/hyperactivity disorder. Expert Rev Neurother 8(4): 611–25.
Krause KH, Dresel SH et al. (2000). Increased striatal dopamine transporter in adult patients with attention deficit hyperactivity disorder: effects of methylphenidate as measured by single photon emission computed tomography. Neurosci Lett 285(2): 107–10.
Kusaga A, Yamashita Y et al. (2002). Increased urine phenylethylamine after methylphenidate treatment in children with ADHD. Ann Neurol 52(3): 372–4.
Laucht M, Skowronek M et al. (2007). Interacting effects of the dopamine transporter gene and psychosocial adversity on attention-deficit/hyperactivity disorder symptoms among 15-year-olds from a high-risk community sample. Arch Gen Psychiatry 64(5): 585–90.
Leo D, Sorrentino E et al. (2003). Altered midbrain dopaminergic neurotransmission during development in an animal model of ADHD. Neurosci Biobehav Rev 27(7): 661–9.
Leonard BE, McCartan D et al. (2004). Methylphenidate: a review of its neuropharmacological, neuropsychological and adverse clinical effects. Hum Psychopharmacol 19(3): 151–80.
Li D, Sham PC et al. (2006). Meta-analysis shows significant association between dopamine system genes and attention deficit hyperactivity disorder (ADHD). Hum Mol Genet 15(14): 2276–84.
Li J, Wang Y et al. (2007). Association between polymorphisms in serotonin transporter gene and attention deficit hyperactivity disorder in Chinese Han subjects. Am J Med Genet B Neuropsychiatr Genet 144B(1): 14–9.
Lucki I (1998). The spectrum of behaviors influenced by serotonin. Biol Psychiatry 44(3): 151–62.
Madras BK, Miller GM et al. (2005). The dopamine transporter and attention-deficit/hyperactivity disorder. Biol Psychiatry 57(11): 1397–409.
Malmberg K, Wargelius HL et al. (2008). ADHD and Disruptive Behavior scores – associations with MAO-A and 5-HTT genes and with platelet MAO-B activity in adolescents. BMC Psychiatry 8: 28.
Manzke T, Guenther U, Ponimaskin EG, Haller M, Dutschmann M, Schwarzacher S, Richter DW (2003). 5-HT4(a) receptors avert opioid-induced breathing depression without loss of analgesia. Science 301: 226–229.
Martin KF, Webb AR et al. (1987). The behavioural response to the 5-hydroxytryptamine1B (5HT1B) receptor agonist–RU-24969 may exhibit a circadian variation in the mouse. Chronobiol Int 4(4): 493–8.
Mazei MS, Pluto CP et al. (2002). Effects of catecholamine uptake blockers in the caudate-putamen and subregions of the medial prefrontal cortex of the rat. Brain Res 936(1–2): 58–67.
Mick E, Faraone SV (2008). Genetics of attention deficit hyperactivity disorder. Child Adolesc Psychiatr Clin N Am 17(2): 261–84, vii–viii.
Mill J, Sagvolden T et al. (2005). Sequence analysis of Drd2, Drd4, and Dat1 in SHR and WKY rat strains. Behav Brain Funct 1: 24.
Naaijen J, Forde NJ, Lythgoe DJ, Akkermans SE, Openeer TJ, Dietrich A, Zwiers MP, Hoekstra PJ, Buitelaar JK (2016). Fronto-striatal glutamate in children with Tourette`s disorder and attention-deficit/hyperactivity disorder. Neuroimage Clin 13: 16–23.
Neuman RJ, Lobos E et al. (2007). Prenatal smoking exposure and dopaminergic genotypes interact to cause a severe ADHD subtype. Biol
